United Capital Financial Advisors LLC Has $15.26 Million Holdings in UnitedHealth Group Incorporated $UNH

United Capital Financial Advisors LLC raised its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 36,707 shares of the healthcare conglomerate’s stock after acquiring an additional 2,087 shares during the quarter. United Capital Financial Advisors LLC’s holdings in UnitedHealth Group were worth $15,256,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Norges Bank acquired a new position in UnitedHealth Group during the fourth quarter valued at approximately $4,376,167,000. Corient Private Wealth LP bought a new position in UnitedHealth Group in the 2nd quarter worth $245,516,000. Legal & General Group Plc bought a new stake in UnitedHealth Group during the second quarter valued at about $2,444,928,000. Jupiter Topco LLC bought a new position in shares of UnitedHealth Group in the second quarter worth about $2,019,844,000. Finally, BlackRock Inc. boosted its stake in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $393.99 on Friday. The company has a quick ratio of 0.78, a current ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a 50-day moving average price of $413.28 and a 200 day moving average price of $360.11. The firm has a market capitalization of $353.64 billion, a PE ratio of 25.35, a price-to-earnings-growth ratio of 1.36 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $255.96 and a 12-month high of $461.62.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.94 by $1.44. The business had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Research analysts anticipate that UnitedHealth Group Incorporated will post 19.82 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 22nd. Stockholders of record on Monday, September 14th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio is presently 59.72%.

Analyst Ratings Changes

A number of research analysts have recently commented on UNH shares. DA Davidson set a $512.00 price target on UnitedHealth Group in a report on Tuesday, July 21st. BMO Capital Markets set a $512.00 target price on shares of UnitedHealth Group in a research note on Tuesday, July 21st. Morgan Stanley raised their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Erste Group Bank downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Robert W. Baird raised UnitedHealth Group from an “underperform” rating to a “neutral” rating and upped their price target for the company from $287.00 to $453.00 in a report on Thursday, July 16th. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $456.56.

Insider Transactions at UnitedHealth Group

In related news, CEO Patrick Hugh Conway sold 1,169 shares of UnitedHealth Group stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.19% of the stock is owned by corporate insiders.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.